DYRK1A and Alzheimer disease: HQSAR (2D fragment-based) models were developed for 46 6-arylquinazolin-4-amines (N training = 36; N test = 10), a series of inhibitors for DYRK1A, an enzyme associated with Alzheimer’s disease.